Claims-based diagnostic and procedure codes are valid for identifying certain cardiovascular and gastrointestinal serious adverse events in pharmacoepidemiology research.
The results suggest that, for certain adverse events, claims data can serve as the basis for pharmacoepidemiology research and drug safety surveillance in the US.
Wahl et al. (Fri,) studied this question.